Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does AMLODIPINE Cause Pulmonary valve incompetence? 16 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 16 reports of Pulmonary valve incompetence have been filed in association with AMLODIPINE (Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide). This represents 0.0% of all adverse event reports for AMLODIPINE.

16
Reports of Pulmonary valve incompetence with AMLODIPINE
0.0%
of all AMLODIPINE reports
0
Deaths
13
Hospitalizations

How Dangerous Is Pulmonary valve incompetence From AMLODIPINE?

Of the 16 reports, 13 (81.3%) required hospitalization.

Is Pulmonary valve incompetence Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for AMLODIPINE. However, 16 reports have been filed with the FAERS database.

What Other Side Effects Does AMLODIPINE Cause?

Hypotension (6,504) Toxicity to various agents (5,554) Completed suicide (5,267) Drug ineffective (4,091) Dyspnoea (3,907) Dizziness (3,536) Intentional overdose (3,427) Fall (3,215) Fatigue (3,141) Headache (2,907)

What Other Drugs Cause Pulmonary valve incompetence?

FENFLURAMINE (163) ONDANSETRON (97) CLOZAPINE (69) ARIPIPRAZOLE (30) ZOMETA (28) AREDIA (23) VALSARTAN (23) HYDROCHLOROTHIAZIDE\VALSARTAN (20) DIAZEPAM (19) ATORVASTATIN (18)

Which AMLODIPINE Alternatives Have Lower Pulmonary valve incompetence Risk?

AMLODIPINE vs AMLODIPINE BESILATE AMLODIPINE vs AMLODIPINE\ATORVASTATIN AMLODIPINE vs AMLODIPINE\BENAZEPRIL AMLODIPINE vs AMLODIPINE\HYDROCHLOROTHIAZIDE\OLMESARTAN AMLODIPINE vs AMLODIPINE\HYDROCHLOROTHIAZIDE\OLMESARTAN MEDOXOMIL

Related Pages

AMLODIPINE Full Profile All Pulmonary valve incompetence Reports All Drugs Causing Pulmonary valve incompetence AMLODIPINE Demographics